Shuttle Pharmaceuticals Cash Over Time
| SHPH Stock | USD 0.86 0.01 1.15% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Shuttle Pharmaceuticals Performance and Shuttle Pharmaceuticals Correlation. Shuttle |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.25) | Return On Assets (0.62) | Return On Equity (1.86) |
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Analysis
Compare Shuttle Pharmaceuticals and related stocks such as Lifecore Biomedical, Catalent, and Lucy Scientific Discovery Cash Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LFCR | 14.2 M | 22.2 M | 13.7 M | 14.2 M | 14.1 M | 9.9 M | 5.4 M | 2.9 M | 1.1 M | 360 K | 1.3 M | 1.6 M | 1.6 M | 8.5 M | 10.6 M |
| CTLT | 139 M | 139 M | 106.4 M | 74.4 M | 151.3 M | 131.6 M | 288.3 M | 410.2 M | 345.4 M | 953.2 M | 896 M | 449 M | 280 M | 289 M | 381.9 M |
| TLRY | 23.8 K | 23.8 K | 9.7 K | 5.7 M | 5.7 M | 12.6 M | 59.3 M | 46.3 M | 407.1 M | 358.5 M | 488.5 M | 415.9 M | 206.6 M | 228.3 M | 189.1 M |
| ORGO | 199.4 K | 126.1 K | 126.1 K | 126.1 K | 126.1 K | 126.1 K | 1 M | 125.9 K | 21.3 M | 60.2 M | 84.4 M | 113.9 M | 102.5 M | 104.3 M | 53.7 M |
| DERM | 55.4 M | 55.4 M | 55.4 M | 55.4 M | 55.4 M | 107.2 M | 41.8 M | 295.9 M | 105 M | 4.8 M | 8.2 M | 49.1 M | 32 M | 27.4 M | 26.1 M |
| AKAN | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 13.5 K | 3.5 M | 228.8 K | 93.9 K | 89.2 K |
Shuttle Pharmaceuticals and related stocks such as Lifecore Biomedical, Catalent, and Lucy Scientific Discovery Cash description
Cash refers to the most liquid asset of Shuttle Pharmaceuticals, which is listed under current asset account on Shuttle Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Shuttle Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Shuttle Pharmaceuticals account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.My Equities
My Current Equities and Potential Positions
| Shuttle Pharmaceuticals | SHPH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Maryland; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.86
Check out Shuttle Pharmaceuticals Performance and Shuttle Pharmaceuticals Correlation. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.